levodopa has been researched along with Constriction, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clemenceau, S; Czernecki, V; Heran, F; Itti, E; Kinugawa, K; Lepeintre, JF; Mari, I; Roze, E; Vidailhet, M | 1 |
| Hayashi, Y; Hozumi, I; Inuzuka, T; Kimura, A; Sakurai, T; Tanaka, Y; Yamada, M | 1 |
| Asamoto, S; Doi, H; Hirabayashi, K; Matsumoto, K; Nakama, H; Sugiura, K; Sugiyama, H; Tanaka, S; Yokochi, M | 1 |
| Kawasoe, T; Miyata, S; Ochiai, H; Yamakawa, Y | 1 |
1 review(s) available for levodopa and Constriction, Pathologic
| Article | Year |
|---|---|
Levodopa effective parkinsonism associated with aqueductal stenosis: a case report and review of the literature.
Topics: Adolescent; Cerebral Aqueduct; Constriction, Pathologic; Female; Humans; Hydrocephalus; Levodopa; Parkinson Disease; Ventriculoperitoneal Shunt | 1998 |
3 other study(ies) available for levodopa and Constriction, Pathologic
| Article | Year |
|---|---|
Subacute dopa-responsive Parkinsonism after successful surgical treatment of aqueductal stenosis.
Topics: Antipsychotic Agents; Cerebral Aqueduct; Constriction, Pathologic; Humans; Hydrocephalus; Injections, Subcutaneous; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed, Single-Photon; Tropanes | 2009 |
[Rapidly progressive parkinsonism that developed one year after ventriculoperitoneal shunting for idiopathic aqueductal stenosis: a case report].
Topics: Acute Disease; Cerebral Aqueduct; Constriction, Pathologic; Disease Progression; Female; Humans; Levodopa; Middle Aged; Parkinsonian Disorders; Postoperative Complications; Syndrome; Treatment Outcome; Ventriculoperitoneal Shunt | 2010 |
[L-dopa effective parkinsonism appeared after shunt revision of the aqueductal stenosis: report of two cases].
Topics: Adult; Antiparkinson Agents; Cerebral Aqueduct; Constriction, Pathologic; Female; Humans; Hydrocephalus; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Ventriculoperitoneal Shunt | 2000 |